Zostavax Vaccine Lawsuit Filed Over Vestibular Neuritis Diagnosis, Shingles And Hearing Loss

According to allegations raised in a product liability lawsuit filed against Merck, a California woman not only developed shingles shortly after receiving a vaccine to prevent the condition, but side effects of the Zostavax vaccine left her with vestibular neuritis and hearing loss as well.

The complaint (PDF) was filed by Lucy Pettaway in the U.S. District Court for the Eastern District of Pennsylvania on June 6, indicating that Merck sold the developed, manufactured and sold a shingles vaccine that was unreasonably dangerous, increasing the risk of more severe and persistent shingles outbreaks, and other auto-immune reactions.

Pettaway indicates that she was injected with the single-dose shingles vaccine Zostavax in June 2017, which has been commonly given to older adults as a preventative measure to avoid the development of shingles. However, due to an under-attenuated version of the live virus contained in the vaccine, it has been linked to a large number of complications and injuries after activating the dormant virus in some individuals.

Learn More About

Zostavax Lawsuits

Side effects of the shingles vaccine Zostavax may result in the development of a painful and persistent strain of shingles

Learn More About this Lawsuit SEE IF YOU QUALIFY FOR COMPENSATION

Later the same month she was vaccinated, Pettaway indicates that she developed a severe rash, which was later diagnosed as shingles; the ailment the shot was supposed to prevent. She also began having hearing loss and was later diagnosed with vestibular neuritis, which is a condition that affects the nerves of the inner ear and can cause hearing damage, dizziness, balance problems, nausea, vomiting and vertigo.

“Even though Merck knew or should have known of the risks and reactions [with Zostavax], it still failed to provide warnings that accurately reflected the signs, symptoms, incident, scope, or severity of the risks associated with the product,” Pettaway alleges in the complaint. “Merck, as a manufacturer of pharmaceutical products, is held to the level of knowledge of an expert in the field and, further, Merck had knowledge ofthe dangerous risks and side effects of its product. Plaintiff did not have the same knowledge as Merck and no adequate warning was communicated to her physician(s) and/or healthcare providers.”

The case joins hundreds of similarĀ Zostavax lawsuits over the single-shot vaccine, which has now been largely replaced by the newer Shingrix vaccine, which involves two doses and is widely viewed as a safer product.

Given similar questions of fact and law raised in the complaints filed by Pettaway and other plaintiffs, the federal litigation has been centralized before U.S. District Judge Harvey Bartle III in the Eastern District of Pennsylvania, for coordinated discovery and pretrial proceedings as part of a federal MDL, or multi-district litigation.

As lawyers continue to investigate and file additional claims on behalf of people who have experienced problems from Zostavax, the size of the litigation is expected to continue to grow over the coming months and years. If Merck fails to reach Zostavax settlements or another resolution for the claims following bellwether trials, each individual lawsuit may eventually be remanded back to different U.S. District courts nationwide for separate trial dates in the future.

3 Comments

  • ElizabethMarch 8, 2024 at 3:33 am

    I had first shindrex vaccine end of 2023 second one end of January 2024 4 days later ear problem started now diagnosed with Labrinthitis but most likely to be Vestibular neurosis as i am being sent to balance clinic and have been prescribed Prednisolone i wouldn't recommend the shingles vaccine to anyone.

  • LisaMay 5, 2022 at 6:37 pm

    Never had balance problems until my 1st injection for shingles. At which time I experienced a rash and vertigo. After that was cleared up I took my booster for shingles. And within 2 weeks had another attack of vertigo. I've had 3 major episodes since 01/22. I was told today that I have recurrent chronic vestibular neuritis and that I am now consider disabled and should file for Disability. I am 1[Show More]Never had balance problems until my 1st injection for shingles. At which time I experienced a rash and vertigo. After that was cleared up I took my booster for shingles. And within 2 weeks had another attack of vertigo. I've had 3 major episodes since 01/22. I was told today that I have recurrent chronic vestibular neuritis and that I am now consider disabled and should file for Disability. I am 100% sure that my illness was caused by the shingles vaccine recommended for all adults over 60.

  • KathleenDecember 27, 2020 at 2:20 am

    I received Zostavax in January 2015. I later developed vestibular neuritis and continue to experience dizziness. The effects continue to affect my life on a daily basis; it took more than a year to get a correct diagnosis.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL
Leadership Development Committee for Suboxone Dental Injury Lawyers Established in Federal MDL (Posted 2 days ago)

The U.S. District Judge presiding over all Suboxone lawsuits has created a mentorship program to use the litigation to provide some attorneys an opportunity to gain experience in handling complex federal multidistrict litigations.

Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M
Gilead Settlement Resolves 2,625 HIV Drug Lawsuits Pending in Federal Courts for $40M (Posted 4 days ago)

Gilead says it will pay $40 million to resolve HIV drug lawsuits over Truvada, Atripla, Viread, Stribild and Complera pending in the federal court system, involving claims that the the company sat on safer formulations of the drugs for years to increase profits.